This activity will address the urgent needs of patients with type 1 and type 2 diabetes who require complex diabetes treatment in the primary care setting in the time of COVID-19 by empowering and increasing the capacity of primary care providers (PCPs) and clinics to safely and effectively manage underserved patients who do not have access to routine specialty care.
Led by a nationally/internationally renowned faculty team of diabetes experts (many of whom contribute to/co-author national guideline recommendations), this curriculum will spotlight various aspects of diabetes management for patients at high-risk for poor outcomes during the time of COVID-19.
Wednesday, August 19, 2020
9:00am – 10:15am
Free webinar series offered at 9:00 am – 10:15 am (PT) every Wednesday. Registration is required.
This Week’s Speaker
Diabetes & Substance Abuse in the Time of COVID-19
Justin Altschuler, MD, MS
AMA PRA Category 1 Credits™ (1.25 hours), Non-Physician Participation Credit (1.25 hours)
- Describe why patients with diabetes are prone to substance use disorders (SUDs).
- Review implications of COVID-19 on SUDs in patients with diabetes.
- Identify the goals of care for patients with diabetes with active substance abuse disorders, and those in remission.
- Discuss pharmacologic and other treatments for SUDs in the time of COVID-19.
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.